Treatment of invasive aspergillosis with itraconazole

D.W. Denning; R.M. Tucker; L.H. Hansen; D.A. Stevens

doi:10.1016/0002-9343(89)90475-0

Treatment of invasive aspergillosis with itraconazole

D.W. Denning
, R.M. Tucker
, L.H. Hansen
, D.A. Stevens

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

PURPOSE:
Invasive aspergillosis in the immunocompromised host is one of the most difficult therapeutic problems. Itraconazole, a new oral triazole, is inhibitory as well as fungicidal against Aspergillus species in vitro. It is active against Aspergillus infections in animal models. We present our experience with itraconazole therapy of 21 patients with aspergillosis.

Original language	English
Pages (from-to)	791-800
Number of pages	2
Journal	The American Journal of Medicine
Volume	86
Issue number	6 C
DOIs	https://doi.org/10.1016/0002-9343(89)90475-0
Publication status	Published - 1989

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/0002-9343(89)90475-0

Cite this

@article{e68bb89550344fc2ac10de90aec0225b,

title = "Treatment of invasive aspergillosis with itraconazole",

abstract = "PURPOSE: Invasive aspergillosis in the immunocompromised host is one of the most difficult therapeutic problems. Itraconazole, a new oral triazole, is inhibitory as well as fungicidal against Aspergillus species in vitro. It is active against Aspergillus infections in animal models. We present our experience with itraconazole therapy of 21 patients with aspergillosis. ",

author = "D.W. Denning and R.M. Tucker and L.H. Hansen and D.A. Stevens",

year = "1989",

doi = "10.1016/0002-9343(89)90475-0",

language = "English",

volume = "86",

pages = "791--800",

journal = "The American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier BV",

number = "6 C",

}

TY - JOUR

T1 - Treatment of invasive aspergillosis with itraconazole

AU - Denning, D.W.

AU - Tucker, R.M.

AU - Hansen, L.H.

AU - Stevens, D.A.

PY - 1989

Y1 - 1989

N2 - PURPOSE: Invasive aspergillosis in the immunocompromised host is one of the most difficult therapeutic problems. Itraconazole, a new oral triazole, is inhibitory as well as fungicidal against Aspergillus species in vitro. It is active against Aspergillus infections in animal models. We present our experience with itraconazole therapy of 21 patients with aspergillosis.

AB - PURPOSE: Invasive aspergillosis in the immunocompromised host is one of the most difficult therapeutic problems. Itraconazole, a new oral triazole, is inhibitory as well as fungicidal against Aspergillus species in vitro. It is active against Aspergillus infections in animal models. We present our experience with itraconazole therapy of 21 patients with aspergillosis.

UR - https://www.scopus.com/pages/publications/0024319962

U2 - 10.1016/0002-9343(89)90475-0

DO - 10.1016/0002-9343(89)90475-0

M3 - Article

SN - 0002-9343

VL - 86

SP - 791

EP - 800

JO - The American Journal of Medicine

JF - The American Journal of Medicine

IS - 6 C

ER -

Treatment of invasive aspergillosis with itraconazole

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this